Month 2014
Mercury(II) Chloride-Mediated Desulphurization of Amidinothioureas: Synthesis and
Antimicrobial Activity of 3-Amino-1,2,4-triazole Derivatives
(150MHz, CDCl3) d (ppm): 116.38, 120.56, 125.27, 127.90,
128.33, 128.59, 128.90, 129.05, 130.04, 138.30, 140.71, 152.34,
159.92. HRMS (TOFMS ES+) Calcd for C20H16N4 (M+ 1)+
313.1453, found 313.1441.
129.23, 129.96, 130.57, 138.38, 146.78, 152.26, 159.90. HRMS
(TOFMS ES+) Calcd for C21H18N4O (M + 1)+ 343.1559, found
343.1525.
N-(4-Bromophenyl)-1,5-diphenyl-1H-1,2,4-triazol-3-amine
5-Methyl-N,1-diphenyl-1H-1,2,4-triazol-3-amine (4b). White
(4i).
White solid, mp 256–258ꢀC, Rf: 0.5 (hexane:ethyl acetate
solid, mp 168–170ꢀC, Rf: 0.3 (hexane:ethyl acetate 1.5:0.5),
1.5:1), IR (KBr, cmꢁ1: 3276.47, 3198.73, 2362.37, 1882.18,
IR (KBr, cmꢁ1
:
3256.22, 3091.33, 1598.70, 1557.24,
1608.34, 1287.11.), H-NMR (600 MHz, CDCl3) d (ppm): 6.8 (s,
1
1494.56,1340.28.), 1H-NMR (600 MHz, CDCl3) d (ppm): 2.52 (s,
3H, —CH3); 6.92 (s, 1H, —NH—); 6.93–7.54 (m, 10H, ArH).
13C-NMR (150 MHz, CDCl3) d (ppm): 13.0, 117.0, 120.0, 123,
129, 130.1, 139.1, 140.1, 156, 160. GC–MS (M+) 250.
1H, —NH—); 7.3–7.7 (m, 13H, ArH). 13C-NMR (150MHz,
CDCl3) d (ppm): 112.65, 118.02, 125.26, 128.84, 125.26, 128.49,
128.61, 128.84, 129.33, 130.13, 131.88, 139.78. HRMS (TOFMS
ES+) Calcd for C20H15BrN4 (M+ 1)+ 391.0558, found 391.0587.
1,5-Diphenyl-N-trityl-1H-1,2,4-triazol-3-amine (4j). White
solid, mp 160–162ꢀC, Rf: 0.6 (hexane:ethyl acetate 1.5:1), IR
(KBr, cmꢁ1 : 3245.61, 3061.44, 2931.27, 1541.81, 1174.44,
772.351.), 1H-NMR (600 MHz, CDCl3) d (ppm): 2.1 (s, 3H, —CH3);
5.6 (s, 1H, —NH—); 7.1–7.7 (m, 21H, ArH). 13C-NMR
(150 MHz, CDCl3) d (ppm): 14.32, 72.07, 123.96, 127.01,
127.93, 128.08, 128.77, 129.98, 136.81, 145.01, 153.03,
158.63. HRMS (TOFMS ES+) Calcd for C28H24N4 (M + Na)+
439.1899, found 439.1934.
N-(4-Chlorophenyl)-1,5-diphenyl-1H-1,2,4-triazol-3-amine
(4c).
White solid, mp 240–242ꢀC, Rf: 0.5 (hexane:ethyl acetate
1.5:1), IR (KBr, cmꢁ1: 3276.47, 3199.33, 3070.12, 1887.97, 1603.52,
1
1551.45.), H-NMR (600 MHz, CDCl3) d (ppm): 6.92 (s, 1H, —
NH—); 7.23–7.50 (m, 14H, ArH). 13C-NMR (150 MHz, CDCl3) d
(ppm): 117.59, 125.26, 127.74, 128.48, 128.62, 128.86, 128.94,
129.32, 130.14, 138.19, 139.34, 152.46, 159.62. HRMS (TOFMS ES
+) Calcd for C20H15ClN4 (M + 1)+ 347.1063, found 347.1074.
N-(4-Chlorophenyl)-5-methyl-1-phenyl-1H-1,2,4-triazol-3-
amine (4d).
White solid, mp 190–192ꢀC, Rf: 0.4 (hexane:ethyl
acetate 1.5:1), IR (KBr, cmꢁ1 : 3266.82, 2931.27, 1557.24,
1334.50, 1097.30, 823.455.), 1H-NMR (600 MHz, CDCl3) d
(ppm): 2.50 (s, 3H, —CH3); 6.85 (s, 1H, —NH—); 7.24–7.54 (m,
9H, ArH). 13C-NMR (150MHz, CDCl3) d (ppm): 13.30, 117.56,
124.28, 125.20, 128.25, 128.95, 129.39, 137.53, 139.40, 150.88,
159.20. HRMS (TOFMS ES+) Calcd for C15H13ClN4 (M+ 1)+
285.0907, found 285.0899.
1,5-Diphenyl-N-p-tolyl-1H-1,2,4-triazol-3-amine (4e). White
solid, mp 225–228ꢀC, Rf: 0.6 (hexane:ethyl acetate 1.5:1), IR
(KBr, cmꢁ1: 3282.25, 3199.33, 3075.90, 1960.29, 1882.18, 1551.45.),
1H-NMR (600 MHz, CDCl3) d (ppm): 2.35 (s, 3H, —CH3);
6.8 (s, 1H, —NH—); 7.1–7.7 (m, 14H, ArH). 13C-NMR
(150 MHz, CDCl3) d (ppm): 20.67, 117.51, 125.25, 127.98,
128.56, 128.88, 129.24, 129.54, 129.92, 129.98, 137.53,
138.34, 152.29, 160.12. HRMS (TOFMS ES+) Calcd for
C21H18N4 (M + 1)+ 327.1610, found 327.1579.
1,5-Diphenyl-N-o-tolyl-1H-1,2,4-triazol-3-amine (4f). White
solid, mp 138–140ꢀC, Rf: 0.46 (hexane:ethyl acetate 1.5:1), IR
(KBr, cmꢁ1 : 3437.49, 3281.29, 3062.41, 1556.27, 1447.31,
1321.96.), 1H-NMR (600 MHz, CDCl3) d (ppm): 2.4 (s, 3H, —CH3);
6.6 (s, 1H, —NH—); 6.9–8.4 (m, 14H, ArH) 13C-NMR
(150 MHz, CDCl3) d (ppm): 17.85, 116.31, 120.65, 123.61,
125.25, 127.17, 127.92, 128.83, 129.27, 128.85, 129.27, 130.03,
130.23, 138.21, 138.95, 152.37, 160.02. HRMS (TOFMS ES+)
Calcd for C21H18N4 (M + 1)+ 327.1610, found 327.1612.
N-(4-Methoxyphenyl)-1,5-diphenyl-1H-1,2,4-triazol-3-amine
(4g). White solid, mp 232–234ꢀC, Rf: 0.4 (hexane:ethyl acetate
1.5:1), IR (KBr, cmꢁ1 : 3282.25, 2997.82, 1614.13, 1237.11.),
1H-NMR (600 MHz, CDCl3) d (ppm): 3.8 (s, 3H, —OCH3); 6.9
(s, 1H, —NH—); 7.2–7.7 (m, 14H, ArH). 13C-NMR (150 MHz,
CDCl3) d (ppm): 55.62, 114.40, 118.02, 125.24, 127.99, 128.24,
128.55, 128.88, 129.23, 129.97, 134.43, 138.34, 152.33, 153.98,
160.36. HRMS (TOFMS ES+) Calcd for C21H18N4O (M+ 1)+
343.1559, found 343.1527.
REFERENCES AND NOTES
[1] Beria, I.; Pesenti, E.; Capolongo, L.; Mongelli, N.; Baraldi, P.
PCT Intl Appl WO 9605196 A1, 1996.
[2] Bignon, E.; Bras, J.-P.; De Cointet, P.; Despeyroux, P.;
Frehel, D.; Gully, D. PCT Intl Appl WO 034729 A1, 2002.
[3] Akerblom, E. B.; Campbell, D. E. S. J Med Chem 1973,
16, 312.
[4] Naito, Y.; Akahoshi, F.; Takeda, S.; Okada, T.; Kajii, M.;
Nishimura, H.; Sigiura, M.; Fukaya, C.; Kagitani, Y. J Med Chem 1996,
39, 3019.
[5] For the solid phase synthesis of 3-amino-1,2,4 triazole (a)
Makara, G. M.; Ma, Y.; Margarida, L. Org Lett 2002, 4, 1751; (b)
Yu, Y.; Ostresh, J. M.; Houghten, R. A. Tetrahedron Lett 2003,
44, 7841.
[6] Reimlinger, H.; Billiau, F.; Lingier, W. R. F. Synthesis 1970,
260; (b) Reimlinger, H.; Lingier, W. R. F.; Vandewalle, J. J. M. Synthesis
1970, 433.
[7] Gyorgydeak, Z.; Holzer, W. Heterocycles 1998, 48, 1395.
[8] Chen, C.; Dagnino, R.; Huang, C. Q.; McCarthy, J. R.; Grigoriadis,
D. E. Bioorg Med Chem Lett 2001, 11, 3165.
[9] Kaila, J. C.; Baraiya, A. B.; Pandya, A. N.; Jalani,
H. B.; Sudarsanam, V.; Vasu, K. K. Tetrahedron Lett 2008,
49, 7220.
[10] Kaila, J. C.; Baraiya, A. B.; Pandya, A. N.; Jalani, H. B.; Vasu,
K. K.; Sudarsanam, V. Tetrahedron Lett 2009, 50, 3955.
[11] Scheiff, A. B.; Yerande, S. G.; El-Tayeb, A.; Li, W.; Inamdar,
G. S.; Vasu, K. K.; Sudarsanam, V.; Müller C. E. Bioorg Med Chem
2010, 18, 2195.
[12] For precedent of carbodiimide as intermediate in the
mechanism proposed from thioureas, see: (a) Poss, M. A.; Iwanowicz,
E.; Reid, J. A.; Lin, J.; Gu, Z. Tetrahedron Lett 1992, 33, 5933; (b)
Kim, K. S.; Qian, L.; Tetrahedron Lett 1993, 48, 7677; Levallet, C.;
Lerpiniere, J.; Ko, S. Y.; Tetrahedron 1997, 53, 5291.
[13] For precedent of the addition-elimination mechanism proposal
from thioureas, see: (a) Wermann, K.; Walther, M.; Günther, W.;
Görls, H.; Anders, E. Tetrahedron 2005, 61, 673; (b) Wermann, K.;
Walther, M.; Günther, W.; Görls, H.; Anders, E. J Org Chem 2001,
66, 720.
[14] C. Sherman, Chemical Agents of Control: Chemotherapeutic
Agents, 7th edn, Tata Art Printers, 2005, 279.
[15] Swamy, S. N.; Bassapa; Sarala, G.; Priya, B. S.; Gaonkar, S. L.;
Prasad, J. S.; Rangappa, K. S. Bioorg Med Chem Lett 2006, 16, 999.
[16] Kotharkar, S. A.; Shinde D. B. Bioorg Med Chem Lett 2006,
16, 6181.
N-(2-Methoxyphenyl)-1,5-diphenyl-1H-1,2,4-triazol-3-amine
(4h). White solid, mp 130–132ꢀC, Rf: 0.5 (hexane:ethyl acetate
1.5:1), IR (KBr, cmꢁ1 : 3421.10, 3390.24, 3054.69, 2925.48,
1887.97, 1603.52, 1241.93.), 1H-NMR (600 MHz, CDCl3) d
(ppm): 3.95 (s, 3H, —OCH3); 7.0 (s, 1H, —NH—); 6.9–7.7 (m,
14H, ArH). 13C-NMR (150 MHz, CDCl3) d (ppm): 55.71, 109.70,
115.75, 119.90, 121.22, 125.23, 128.03, 128.24, 128.54, 128.87,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet